書誌事項
- タイトル別名
-
- Metabolism of 2,2ʼ,3,4,4ʼ,5,5ʼ-Heptachlorobiphenyl (CB180) by Animal Liver Microsomes
- 2,2',3,4,4',5,5'-七塩素化ビフェニル(CB180)の動物肝ミクロゾームによる代謝
- 2,2',3,4,4',5,5'-ナナ エンソカ ビフェニル(CB180)ノ ドウブツ カン ミクロゾーム ニ ヨル タイシャ
この論文をさがす
抄録
The in vitro metabolism of 2,2ʼ,3,4,4ʼ,5,5ʼ-heptachlorobiphenyl (CB180) was examined using liver microsomes of rats, guinea pigs and hamsters. Of liver microsomes from untreated animals, rats and guinea pigs produced one metabolite (M-1) with the activity of 1.2 and 18.1 pmol/hr/mg protein, respectively, but hamsters did not at all. Pretreatment of phenobarbital (PB) resulted in about 32-fold increase in rats, 4-fold increase in guinea pigs and an appearance of M-1 in hamsters (15 pmol/hr/mg protein). In addition, another metabolite (M-2) was formed only by liver microsomes of PB-treated guinea pigs. In contrast, pretreatment of 3-methylcholanthrene showed no metabolite in three animals. By comparison of the GC-MS data of the metabolites with synthesized authentic samples, M-1 and M-2 was determined to be 3ʼ-hydroxy (OH) -CB180 and 4’-OH-2,2ʼ,3,4,5,5ʼ-hexachlorobiphenyl (CB141), respectively. These results suggest that 3ʼ-OH-CB180 is a major metabolite and is formed by PB-inducible cytochrome P450 (CYP2B enzymes) in animals and also guinea pigs possess much higher activity to metabolize CB180 than rats and hamsters.
収録刊行物
-
- 福岡醫學雜誌
-
福岡醫學雜誌 106 (5), 176-183, 2015-05-25
福岡医学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390853649694635520
-
- NII論文ID
- 120005624046
-
- NII書誌ID
- AN00215478
-
- DOI
- 10.15017/1518707
-
- HANDLE
- 2324/1518707
-
- NDL書誌ID
- 026626554
-
- ISSN
- 0016254X
-
- PubMed
- 26226681
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- IRDB
- NDL
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用可